US Patent 9725449 Tricyclic compounds as anticancer agents

Patent 9725449 was granted and assigned to Bristol-Myers Squibb on August, 2017 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

August 8, 2017

Patent Application Number

15150492

Date Filed

May 10, 2016

Patent Citations Received

Patent Primary Examiner

Patent abstract

The present invention is directed to tricyclic compounds of the formula

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 9725449 Tricyclic compounds as anticancer agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.